Status:
COMPLETED
Chlorhexidine Mouthrinse Before EBUS-TBNA
Lead Sponsor:
Seoul National University Hospital
Conditions:
Endobronchial Ultrasound
Eligibility:
All Genders
19+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate whether chlorhexidine mouthrinse is effective in preventing microbial contamination during endobronchial ultrasound-guided transbronchial needle aspiration ...
Detailed Description
EBUS-TBNA using the convex probe is a standard of care for the assessment of mediastinal and hilar lymphadenopathy. Although EBUS-TBNA is a minimally invasive procedure, rare but serious infectious co...
Eligibility Criteria
Inclusion
- inpatients aged 19 years and older who are scheduled to undergo EBUS-TBNA using a convex probe
Exclusion
- antiseptic mouthrinse within 7 days before inclusion;
- active infection or antibiotic treatment within 7 days before inclusion;
- immunocompromised;
- trachemostomy status;
- who have already undergone gastroscopy on the same day when EBUS- TBNA is scheduled to be administered
Key Trial Info
Start Date :
January 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2021
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04718922
Start Date
January 20 2021
End Date
December 11 2021
Last Update
February 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080